Covidien gets FDA nod for embolic protection device

The FDA has granted Covidien 510(k) clearance for its SpiderFX device, which is used in combination with plaque excision to treat severely calcified lesions in arteries found in the lower extremities. The device is the only embolic protection device cleared in the U.S. for lower extremity use, the company said in a release.

View Full Article in:

Mass High Tech (Boston) · Boston Globe (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD